Bone Health Technologies to Present Clinical Data from Pivotal Trial of Wearable Treatment for Osteopenia in Post-Menopausal Women at Endo 2023
16 juin 2023 14h15 HE
|
Bone Health Technologies
CHICAGO, June 16, 2023 (GLOBE NEWSWIRE) -- Bone Health Technologies (BHT), a pioneer in health technologies for preventing and treating bone health diseases, is presenting pivotal trial data for...
Entera Bio Adds Sanofi Commercial Leader, Haya Taitel to its Board of Directors
07 juin 2023 07h30 HE
|
Entera Bio Ltd.
JERUSALEM, June 07, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update
10 mai 2023 16h05 HE
|
Rani Therapeutics, LLC
- Announced partnership with Celltrion on development of RT-111, a RaniPill GO capsule containing a biosimilar for the monoclonal antibody ustekinumab - - Received preliminary feedback from FDA on...
Entera Bio Announces Q1 2023 Financial Results and Corporate Updates
05 mai 2023 16h05 HE
|
Entera Bio Ltd.
JERUSALEM, May 05, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
Rani Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ
25 avr. 2023 08h00 HE
|
Rani Therapeutics, LLC
SAN JOSE, Calif., April 25, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
11 avr. 2023 08h00 HE
|
Rani Therapeutics, LLC
SAN JOSE, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Entera Bio Provides Guidance from FDA Type D Meeting Related to EB613 Pivotal Program
03 avr. 2023 07h00 HE
|
Entera Bio Ltd.
JERUSALEM, April 03, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
Entera Bio Provides 2022 Corporate Milestones and Financial Results for the Year Ended December 31, 2022
31 mars 2023 16h00 HE
|
Entera Bio Ltd.
JERUSALEM, March 31, 2023 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, today...
New Scientific Evidence Shows Link Between Poor Air Quality and Osteoporosis, Air Filtration Professionals Explain
29 mars 2023 22h18 HE
|
Camfil USA Air Filters
Riverdale, March 29, 2023 (GLOBE NEWSWIRE) -- It is widely accepted that air pollution exposure affects lung and heart health in both the long-term and the short-term, but new evidence continues to...
Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update
22 mars 2023 16h05 HE
|
Rani Therapeutics, LLC
- Anticipates initiating first Phase 2 clinical study in RT-102 in 2H of 2023 - - Announced topline results from the Phase 1 repeat-dose study of RT-102 for the treatment of osteoporosis - -...